GNAS and pulmonary arterial hypertension: In a broader analysis involving 715 PAH patients treated with endothelin receptor antagonists, specific genetic variants, particularly associated with the G protein complex genes GNG2 (G protein subunit gamma 2) and GNAS (guanine nucleotide-binding protein, alpha stimulating), showed strong associations with clinical outcomes [106].